pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›COMPLETEDphase readoutNCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

    Sponsor: Respirion Pharmaceuticals Pty Ltd. Phase: PHASE1. Conditions: Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04933903: BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

    Sponsor: Brown University. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07562061: mulTiplex Immunoassay qualiTy assuRance Panel

    Sponsor: St George's, University of London. Phase: . Conditions: Group B Strep Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00861705: Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIA Breast Cancer AJCC v7, Triple-Negative Breast Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598994: Topical Capsaicin Versus Diclofenac for Chronic Temporomandibular Joint-Related Pain

    Sponsor: Istanbul University. Phase: NA. Conditions: Temporomandibular Disorders (TMD), Temporomandibular Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07061366: The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study.

    Sponsor: Maxima Medical Center. Phase: . Conditions: Preterm, Monitoring

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03879694: Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

    Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Lung Atypical Carcinoid Tumor, Lung Typical Carcinoid Tumor, Metastatic Pancreatic Neuroendocrine Tumor

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06706622: A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

    Sponsor: H. Lundbeck A/S. Phase: PHASE3. Conditions: Multiple System Atrophy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03849651: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), NK-Cell Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma (NHL), Juvenile Myelomonocytic Leukemia (JMML), Chronic Myeloid Leukemia (CML)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07519551: Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength

    Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Osteoporosis, Osteopenia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03466151: RESOLUTE ONYX China RCT Study

    Sponsor: Medtronic Vascular. Phase: NA. Conditions: Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases, Arteriosclerosis, Coronary Artery Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04423029: A Study of DF6002 Alone and in Combination With Nivolumab

    Sponsor: Dragonfly Therapeutics. Phase: PHASE1. Conditions: Solid Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06958653: Gamified Digital Balance Assessment for Older Adults in Community Settings: Development, Validation, and User Experience Evaluation in a Mixed Methods Study

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: ELDERLY PEOPLE, Fall Prevention, Digital Health

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07402837: Creating a Flexible Curriculum Tool for Pediatric Palliative Care Rotating Learners

    Sponsor: Children's National Research Institute. Phase: NA. Conditions: Palliative Care Education

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05491837: Device-induced Intermittent Hypoxia in Persons With Incomplete Spinal Cord Injury

    Sponsor: Riphah International University. Phase: NA. Conditions: Incomplete Spinal Cord Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05479045: A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

    Sponsor: Georgetown University. Phase: PHASE2. Conditions: Ovarian Cancer Stage IV, Ovarian Cancer Stage III, Ovarian Cancer Stage 3

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT07260045: The Effects of Chiropractic on Adults With Depression

    Sponsor: Life University. Phase: NA. Conditions: Depression Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07394972: Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency

    Sponsor: Nicole Stoffel. Phase: NA. Conditions: Iron Deficiency (Without Anemia)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05970172: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

    Sponsor: Astellas Pharma Global Development, Inc.. Phase: PHASE3. Conditions: Chronic Kidney Disease, Renal Anemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05979272: TECH App Marijuana Use Intervention for Court-Involved Adolescents

    Sponsor: Northwestern University. Phase: NA. Conditions: Cannabis Use, Adolescent

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03452072: Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds

    Sponsor: Brigham and Women's Hospital. Phase: PHASE2. Conditions: Wound of Skin, Wound Heal, Wound Open, Surgical Wound

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07135895: The ArtixASCEND Study

    Sponsor: Inari Medical. Phase: NA. Conditions: Acute Lower Limb Arterial Occlusion

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06040645: Outcomes of Urinary Incontinence Treatment in Primary Care: APP Co-Management and Electronic Consult

    Sponsor: University of California, San Diego. Phase: NA. Conditions: Urinary Incontinence

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06323772: Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

    Sponsor: University Hospital Tuebingen. Phase: . Conditions: Retinitis Pigmentosa

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06118372: Recombinant vWF Concentrate and ECMO

    Sponsor: University of Virginia. Phase: PHASE1. Conditions: Bleeding Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07431372: Validation of the Shared Happiness Index in Multidisciplinary Primary Care Practices ( Be aPi )

    Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Well Being

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05916495: An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant

    Sponsor: University of Manchester. Phase: NA. Conditions: Lung Transplant; Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06526195: Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

    Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07248839: A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers, Hepatic Impairment

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02117375: EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Multiple Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05332275: A Media Parenting Prevention Intervention

    Sponsor: University of Florida. Phase: NA. Conditions: Substance Related Problem

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04138277: A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

    Sponsor: Amicus Therapeutics. Phase: PHASE3. Conditions: Pompe Disease (Late-onset)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03910075: Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)

    Sponsor: Virginia Polytechnic Institute and State University. Phase: PHASE3. Conditions: Perinatal Stroke, Hemiparesis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03998501: fMRI to Examine the Effect of CBTm to Increase Resiliency for PTSD

    Sponsor: University of Manitoba. Phase: NA. Conditions: Stress Disorders, Post-Traumatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05923801: Changing Tactics? Optimizing ECT in Difficult-to-treat Depression

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Depression

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06054230: Genomic Sequencing for Evaluation of Fetal Structural Anomalies

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Fetal Structural Anomalies

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05747430: SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

    Sponsor: iRenix Medical, Inc.. Phase: PHASE2. Conditions: Retinal Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07465328: Studying the Impairment of Stroke and Sarcopenia Patients Using Maximum Voluntary Contractions of the Leg Joints.

    Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Sarcopenia, Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02792465: A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

    Sponsor: University Health Network, Toronto. Phase: PHASE1. Conditions: Advanced Solid Cancers, Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07182565: Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

    Sponsor: West China Hospital. Phase: PHASE1. Conditions: Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07216365: Caffeine Optimization for Oxygen Saturation Index in ELBW Infants

    Sponsor: University of Rochester. Phase: PHASE2. Conditions: Neonatal Apnea, Infants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05167565: Longitudinal Development of Behavior and Its Underlying Neural Correlates in Human Infants

    Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05345171: Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency

    Sponsor: Ultragenyx Pharmaceutical Inc. Phase: PHASE3. Conditions: OTC Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05258071: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

    Sponsor: Integrative Research Laboratories AB. Phase: PHASE2. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05203471: Crossing the Divide: Piloting Integrated Care to Reduce Amputations Among Rural Patients With Diabetic Foot Ulcers

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Diabetic Foot, Diabetic Ulcer of Left Foot, Diabetic Ulcer of Right Foot, Amputation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07025083: Adaptation of the Family Check-Up Online

    Sponsor: University of Oregon. Phase: NA. Conditions: Substance Use (Drugs, Alcohol)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07634341: Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial.

    Sponsor: Fayoum University. Phase: PHASE4. Conditions: Chronic Periodontitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02444741: Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Malignant Solid Neoplasm, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04774354: POSSUM, P-POSSUM, Clinical Frailty Scale, Clinical Frailty Scale and Charlson's Comorbidity Index in Abdominal Surgery.

    Sponsor: Ángel Becerra-Bolaños, MD PhD. Phase: . Conditions: Postoperative Complications

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06458205: Impact of Multi-Component Interventions on High-Risk COPD Smokers

    Sponsor: Peking Union Medical College. Phase: NA. Conditions: Multimorbidity, Tobacco Use Cessation, Smoking Reduction

    full page →ctgov ↗
    ← prev
    page 81 of 104
    next →